Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden

Value Health. 2014 Nov;17(7):A545-6. doi: 10.1016/j.jval.2014.08.1767. Epub 2014 Oct 26.

Authors

P Thilakarathne¹, J Diels², S van Sanden³, J Liwing⁴, M Van Agthoven⁵, O Chirita⁶, H Nahi⁷

Affiliations

¹ Janssen Pharmaceutica N. V., Beerse, Belgium.
² Janssen Research & Development, Beerse, Belgium.
³ EMEA HEMAR Analytics, Janssen EMEA, Beerse, Belgium.
⁴ Janssen-Cilag AB, Sollentuna, Sweden.
⁵ Janssen-Cilag BV, Tilburg, The Netherlands.
⁶ Janssen, High Wycombe, UK.
⁷ Karolinska University Hospital, Solna, Sweden.

PMID: 27201764
DOI: 10.1016/j.jval.2014.08.1767

No abstract available